Universal Beteiligungs Und Servicegesellschaft Mb H Biotechnology

Universal Beteiligungs Und Servicegesellschaft Mb H

$56.8 Billion
Q3 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VRTX Vertex Pharmaceuticals Inc	$111B	$125 Million 0.22% of portfolio	319,467	Q3 2025 Added 1.84%
REGN Regeneron Pharmaceuticals, Inc.	$74.3B	$60.7 Million 0.11% of portfolio	108,044	Q3 2025 Added 1.39%
ALNY Alnylam Pharmaceuticals, Inc.	$55.3B	$50.4 Million 0.09% of portfolio	110,552	Q3 2025 Reduced 3.33%
EXEL Exelixis, Inc.	$13.4B	$20.5 Million 0.04% of portfolio	496,791	Q3 2025 Added 8.6%
UTHR United Therapeutics Corp	$21.2B	$16.4 Million 0.03% of portfolio	39,075	Q3 2025 Reduced 10.57%
CRNX Crinetics Pharmaceuticals, Inc.	$2.34B	$16.2 Million 0.03% of portfolio	387,925	Q3 2025 Added 13.53%
INCY Incyte Corp	$23.2B	$16 Million 0.03% of portfolio	188,362	Q3 2025 Added 10.16%
HALO Halozyme Therapeutics, Inc.	$9.75B	$14.3 Million 0.03% of portfolio	195,459	Q3 2025 Reduced 13.51%
IONS Ionis Pharmaceuticals Inc	$10.2B	$12.9 Million 0.02% of portfolio	197,434	Q3 2025 Added 31.76%

BBIO Bridge Bio Pharma, Inc.	$9.84B	$11.5 Million 0.02% of portfolio	222,316	Q3 2025 Added 3.53%
RYTM Rhythm Pharmaceuticals, Inc.	$5.54B	$10.2 Million 0.02% of portfolio	101,372	Q3 2025 Added 6.13%
JAZZ Jazz Pharmaceuticals PLC	$8.84B	$8.58 Million 0.02% of portfolio	65,098	Q3 2025 Reduced 14.98%
AXSM Axsome Therapeutics, Inc.	$5.99B	$8.25 Million 0.01% of portfolio	67,902	Q3 2025 Added 30.66%
PTCT Ptc Therapeutics, Inc.	$5.39B	$8.11 Million 0.01% of portfolio	132,101	Q3 2025 Added 6.24%
INSM Insmed Inc	$26.2B	$7.85 Million 0.01% of portfolio	54,529	Q3 2025 Reduced 36.88%
MDGL Madrigal Pharmaceuticals, Inc.	$9.05B	$7.01 Million 0.01% of portfolio	15,288	Q3 2025 Added 388.28%
HRMY Harmony Biosciences Holdings, Inc.	$2.01B	$6.47 Million 0.01% of portfolio	234,779	Q3 2025 Added 39.3%
KYMR Kymera Therapeutics, Inc.	$3.55B	$6.1 Million 0.01% of portfolio	107,703	Q3 2025 Added 0.25%

PTGX Protagonist Therapeutics, Inc	$4.15B	$6 Million 0.01% of portfolio	90,317	Q3 2025 Added 123.09%
SRRK Scholar Rock Holding Corp	$1.95B	$5.97 Million 0.01% of portfolio	159,741	Q3 2025 Added 108.16%
ARWR Arrowhead Pharmaceuticals, Inc.	$4.37B	$5.55 Million 0.01% of portfolio	160,985	Q3 2025 New
TARS Tarsus Pharmaceuticals, Inc.	$1.92B	$5.44 Million 0.01% of portfolio	91,590	Q3 2025 Added 76.98%
CORT Corcept Therapeutics Inc	$8.09B	$5.41 Million 0.01% of portfolio	65,068	Q3 2025 Reduced 10.38%
BMRN Biomarin Pharmaceutical Inc	$10.2B	$5.21 Million 0.01% of portfolio	96,253	Q3 2025 Added 2.74%
TVTX Travere Therapeutics, Inc.	$2.21B	$5.11 Million 0.01% of portfolio	213,918	Q3 2025 Added 67.67%
VCYT Veracyte, Inc.	$2.82B	$4.21 Million 0.01% of portfolio	122,636	Q3 2025 Added 15.14%
LGND Ligand Pharmaceuticals Inc	$3.39B	$3.87 Million 0.01% of portfolio	21,836	Q3 2025 Reduced 4.32%
TECH Bio Techne Corp	$2.33B	$3.68 Million 0.01% of portfolio	66,186	Q3 2025 Added 54.05%
RVMD Revolution Medicines, Inc.	$5.94B	$3.68 Million 0.01% of portfolio	78,732	Q3 2025 Added 10.41%
RNA Avidity Biosciences, Inc.	$3.69B	$3.49 Million 0.01% of portfolio	80,070	Q3 2025 Reduced 1.58%
NUVL Nuvalent, Inc.	$4.15B	$2.86 Million 0.01% of portfolio	33,084	Q3 2025 Added 8.23%
AGIO Agios Pharmaceuticals, Inc.	$2.39B	$2.86 Million 0.01% of portfolio	71,213	Q3 2025 Added 28.81%
RARE Ultragenyx Pharmaceutical Inc.	$2.32B	$2.75 Million 0.0% of portfolio	91,394	Q3 2025 Added 1.29%
WVE Wave Life Sciences Ltd.	$600M	$2.66 Million 0.0% of portfolio	368,705	Q3 2025 Added 2.87%
FOLD Amicus Therapeutics, Inc.	$2.66B	$2.55 Million 0.0% of portfolio	323,501	Q3 2025 Added 4.93%
CPRX Catalyst Pharmaceuticals, Inc.	$2.38B	$2.54 Million 0.0% of portfolio	129,068	Q3 2025 Reduced 11.39%
TGTX Tg Therapeutics, Inc.	$4.5B	$2.29 Million 0.0% of portfolio	63,298	Q3 2025 Reduced 67.09%
EWTX Edgewise Therapeutics, Inc.	$1.44B	$2.15 Million 0.0% of portfolio	132,503	Q3 2025 Added 0.25%
INVA Innoviva, Inc.	$1.55B	$2.11 Million 0.0% of portfolio	115,503	Q3 2025 Added 838.82%
MRNA Moderna, Inc.	$9.69B	$2.06 Million 0.0% of portfolio	79,899	Q3 2025 Reduced 41.71%
NTLA Intellia Therapeutics, Inc.	$661M	$1.96 Million 0.0% of portfolio	113,438	Q3 2025 Added 74.52%
ARDX Ardelyx, Inc.	$908M	$1.9 Million 0.0% of portfolio	345,077	Q3 2025 Added 6.99%
BEAM Beam Therapeutics Inc.	$1.55B	$1.71 Million 0.0% of portfolio	70,280	Q3 2025 Added 88.85%
CYTK Cytokinetics Inc	$6.25B	$1.69 Million 0.0% of portfolio	30,707	Q3 2025 Added 21.99%
ARQT Arcutis Biotherapeutics, Inc.	$1.5B	$1.63 Million 0.0% of portfolio	86,485	Q3 2025 New
VCEL Vericel Corp	$1.88B	$1.51 Million 0.0% of portfolio	47,993	Q3 2025 Added 4.85%
PCVX Vaxcyte, Inc.	$2.87B	$1.23 Million 0.0% of portfolio	34,150	Q3 2025 Added 32.58%
RXRX Recursion Pharmaceuticals, Inc.	$747M	$1.12 Million 0.0% of portfolio	229,617	Q3 2025 New
LEGN Legend Biotech Corp	$5.07B	$1.05 Million 0.0% of portfolio	32,142	Q3 2025 Added 28.87%
APLS Apellis Pharmaceuticals, Inc.	$2.23B	$1.04 Million 0.0% of portfolio	46,113	Q3 2025 Added 82.46%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Universal Beteiligungs Und Servicegesellschaft Mb H, based on Form 13F filings with the SEC.

News

Stay updated on Universal Beteiligungs Und Servicegesellschaft Mb H with notifications on news.